Business & Finance
Imax remains without suitors nine months after signaling openness to a sale
Despite record box office figures and a soaring stock price, potential buyers face conflict of interest concerns and a rising valuation.
The short version
- Imax CEO Rich Gelfond signaled openness to a sale in December 2025, but the company has not received any official bids or created a formal pitch book.
- Analysts attribute the lack of suitors to conflicts of interest for major Hollywood studios, as well as a steep price tag following an 80% stock surge over the past year.
- The company continues to post record performance, boosted by premium ticket pricing and strong sales from blockbuster releases.
Key facts
- Imax CEO Rich Gelfond indicated in December that the company was open to a sale, leading to preliminary discussions earlier this year but no official bids.[CNBC]
- Imax stock reached an all-time high of $54.79 per share, driving its market capitalization to nearly $3 billion, up from $1.95 billion when a sale was first floated.[CNBC]
- Acquiring Imax poses potential conflicts of interest for traditional movie studios because Imax operates as studio-agnostic, and a single studio could struggle to supply a full year of theatrical content.[CNBC]
- Global Imax ticket sales for Universal's 'The Odyssey' recently exceeded $400 million, representing almost 30% of the film's total global box office off less than 1% of total world screens.[CNBC]
- Average adult Imax tickets in the U.S. cost $20.57 in 2026, which is over 60% higher than standard theater tickets.[CNBC]
What remains uncertain
- It remains uncertain whether any tech companies, private equity firms, or entertainment entities will ultimately submit an acquisition proposal for Imax or wait for share prices to cool.[CNBC]